University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Computer Science and Engineering: Theses,
Dissertations, and Student Research

Computer Science and Engineering, Department
of

Fall 11-30-2022

A Pipeline to Generate Deep Learning Surrogates of GenomeScale Metabolic Models
Achilles Rasquinha
University of Nebraska-Lincoln, achillesrasquinha@gmail.com

Follow this and additional works at: https://digitalcommons.unl.edu/computerscidiss
Part of the Biochemistry Commons, Computer Engineering Commons, Computer Sciences Commons,
and the Structural Biology Commons

Rasquinha, Achilles, "A Pipeline to Generate Deep Learning Surrogates of Genome-Scale Metabolic
Models" (2022). Computer Science and Engineering: Theses, Dissertations, and Student Research. 227.
https://digitalcommons.unl.edu/computerscidiss/227

This Article is brought to you for free and open access by the Computer Science and Engineering, Department of at
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Computer Science and
Engineering: Theses, Dissertations, and Student Research by an authorized administrator of
DigitalCommons@University of Nebraska - Lincoln.

A PIPELINE TO GENERATE DEEP LEARNING SURROGATES OF GENOME-SCALE
METABOLIC MODELS

by

Achilles Rasquinha

A THESIS

Presented to the Faculty of
The Graduate College at the University of Nebraska
In Partial Fulfilment of Requirements
For the Degree of Master of Science

Major: Computer Science

Under the Supervision of Professors
Tomáš Helikar and Massimiliano Pierobon

Lincoln, Nebraska
November, 2022

A PIPELINE TO GENERATE DEEP LEARNING SURROGATES OF GENOME-SCALE
METABOLIC MODELS

Achilles Rasquinha, M.S.
University of Nebraska, 2022

Advisers: Tomáš Helikar & Massimiliano Pierobon

Genome-Scale Metabolic Models (GEMMs) are powerful reconstructions of
biological systems that help metabolic engineers understand and predict growth
conditions subjected to various environmental factors around the cellular
metabolism of an organism in observation, purely in silico. Applications of metabolic
engineering range from perturbation analysis and drug-target discovery to
predicting growth rates of biotechnologically important metabolites and reaction
objectives within different single-cell and multi-cellular organism types. GEMMs
use mathematical frameworks for quantitative estimations of flux distributions
within metabolic networks. The reasons behind why an organism activates, stuns, or
fluctuates between alternative pathways for growth and survival, however, remain
relatively unknown. GEMMs rely on manual intervention during their curation and
annotation process, which can potentially induce substantial experimental bias.
Also, solution spaces that cater to the flux distributions can be sensitive to the
addition,

updates,

and

deletions

of

metabolites

and

reactions

and

gene-enzyme-reaction rules within the model. Therefore, the quest for optimality
can often be lost due to the number of hyper dimensions represented by these
networks

Recently, Deep Learning (DL) has played a significant role in building
function approximators for highly complex input datasets correlating in extremely
large hyper dimensions. In this thesis, to address the computational costs associated
with the simulations of GEMMs, we use an interpretable learning-driven approach
to build surrogate GEMM models that act as alternatives to existent Flux Balance
Analysis (FBA)-based approaches for predicting intracellular fluxes of reactions. We
exploit the network characteristics of a well-curated input organism and build a
synthetic subset of the flux cone containing thermodynamically feasible reaction
growth rates. We then feed this dataset into a deep generative model capable of
reconstructing intracellular flux values of the input organism. We evaluate its
efficiency based on time-to-construct, accuracy, and ease of use. To provide a fair
comparative analysis, we explore our learning approach with other traditional
regression-based models and test our pipeline on three different input organisms
subjected to network reduction techniques and different hyperparameters.
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Chapter 1
Introduction
Genome-Scale Metabolic Modeling (GEMM) provides information on metabolic
activity in an organism and is often considered a de-facto standard in modeling
metabolic-based biochemical systems [1]. GEMM typically represents a snapshot of the
overall

complex

metabolic

activity

within

an

organism

of

interest

[2].

A

well-reconstructed GEMM contains a set of reactions and the various metabolites
constituting them, as well as the gene-protein reaction (GPR) interactions governing
the different possible states across the metabolic network [3]. GEMMs can also be used
to simulate and predict the distribution of metabolic fluxes across reactions within an
organism purely in silico [4]. In practice, GEMMs are capable of predicting the metabolic
flux distribution for a given set of stoichiometry- and mass-balanced-based reactions
of a biochemical system using linear optimization techniques such as Flux Balance
Analysis (FBA) [5], thereby predicting the overall growth rate of an organism or the rate
at which a metabolite is produced.
GEMMs have been applied in the field of strain development to produce
biotechnologically important materials and potential drug target discovery against
infectious microorganisms (bacteria, viruses, etc.) [6]. Flux Balance Analysis (FBA), a
popular metabolic analysis method is often used in resolving knowledge gaps
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(gap-filling) within metabolic networks, thereby refining the overall systematic
investigation of the metabolic activity of organisms purely in silico that would otherwise
be time-consuming and hard to validate in vivo [7]. However, one of the biggest
limitations of such a method is that it is only relevant if the genomic reconstruction of
the network is closely similar to that of the actual wild-type observed. This means that
the model is worthwhile for as long as it has been well-curated, thus limiting itself to
generalization and robustness to variational change concerning annotations, conditions,
and constraints [8].
The first ever known GEMM was one of the Haemophilus influenzae RD in 1999 constituting 343 metabolites and 488 reactions to interpret phenotypic behavior from its
genotypic information embedded within the model [9]. Currently, there are over 6239
manually and automatically curated GEMMs of various bacteria and eukaryotes across a
vast number of databases [10]. In recent years, cell-type specific GEMMs have been
reconstructed to understand diseases within humans, such as obesity, diabetes, etc.,
thanks to the Human Metabolic Reaction (HMR) series of GEMMs for tissue-specific and
cancer-specific cell types [11]. Accurately predicting objectives leading to a disease,
thereby narrowing the bridge between genotype (the encoded information within
organisms) and its phenotype (distinguished characteristics and functions), remains a
problem in exploration.

1.1 Research Challenges
Even with such limitations, there is still no doubt that GEMMs are extremely
relevant in the field of metabolic engineering of biological systems [12]. However, with
the rise in the number of GEMMs reconstructed (especially in the case of cell-specific
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models of the human genome), there is a dearth need for more efficient and scalable
analysis to understand and simulate the complexities of single or multi-cell organisms

Figure 1.1. A phylogenetic tree of all of the GEMs reconstructed to date at the family level.
(Source - [10])

system in silico, particularly in understanding the behaviors and effects as well as the
outcomes of introducing different pathogens within a multi-tissue and multi-organ
system. When there is a widely accepted well-curated GEMM, reaction flux distributions
predicted using

FBA are generally almost consistent with actual lab experimental

conditions [13]. In some cases, such predictions are further enhanced by inducing
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additional information (testing the availability of certain compounds within metabolic
pathways, introducing systematic chemical properties as additional information,
biophysical capabilities, etc.) [14] [15]. As mentioned, although FBA at its core is a form
of mixed integer linear-based optimization, is however limited to the annotated
information provided within the model of interest, i.e., a feasible solution closest to the
actual growth rates within the organism is only replicable if the model in interest has
been qualitatively reconstructed. Therefore, a simple change in the constraint space, be
it internal (gene knockouts) or external (expanding or shrinking bounded solution
space) can heavily affect the growth estimates of such models [8]. Although FBA
provides insights into the outcomes of external constraints imposed, it does not
necessarily speak much on behalf of the constraint space itself. When the metabolic
activity of different pathways is highly sensitive even with extraneous conditions,
providing underlying insights into the genotype-phenotype relationship remains
anything but complex. Also, efficient FBA fundamentally relies on the Moreover, a large
model can present technical limitations in estimating such biological fluxes with an
increase in experimental and environmental parameters. Similarly, simultaneously
simulating a large number of metabolic models (say, a community of models for
instance) could potentially lead to higher computational resource utilization.

1.2 Contributions
In this thesis, we examine the use of Deep Learning as a technique for building
growth simulators as surrogates for Genome-Scale Metabolic Models (GEMMs) with a
major goal of addressing the computational cost challenges associated with GEMM
analysis. A state-of-the-art available Deep Learning model was used and enhanced to
develop predictive simulators that accurately estimate and simulate the metabolic flux
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distribution of a finely reconstructed and well-curated GEMM of an organism of interest
to a very high degree of approximation. The generated and evaluated models from our
Deep Learning-based pipeline are instantaneous in runtime compared to currently
available traditional frameworks [5]. This elevates the scale to compute many GEMM
simulations simultaneously and efficiently, particularly in use cases wherein the closest
system reconstruction to the original biological system is required to achieve a better
understanding of the organism in a given environment (for instance, a digital twin of the
immune system) [16]. It is shown that the proposed pipeline can generate simulated
models within constrained computational time and memory usage and it can mimic
traditional approaches with little to no reconfiguration. Considering such alternative
approaches during perturbation analysis for drug discovery in favor of currently
available methods can enhance the overall pipeline for metabolic-based analysis of
organisms, especially in cases where multiple and parallel flux simulations are expected
to be executed in real-time. The work done within this thesis is available as an
open-sourced package titled “DeepGEMM” for researchers and users to help build
custom surrogates of an input GEMM of choice. It has been released under the GNU
General Public License v3 and is currently being publicly developed and maintained on
GitHub at https://github.com/HelikarLab/DeepGEMM.
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1.3 Thesis Organization
In this section, we discuss the various Chapters covered in this thesis.
●

Chapter 2 discusses the current trends and related work in Machine and Deep
Learning with Genome-Scale Metabolic Modeling.

●

Chapter 3 constructively defines the problem and the details of the
implementation of our proposed framework to predict metabolic fluxes using a
DL approach, experiments conducted to produce our dataset, and simulations to
evaluate flux distributions.

●

In Chapter 4, we discuss the details and results of applying our proposed
methodology.

●

Chapter 5 concludes the thesis and briefly discusses potential future work.

All chapters have been formatted based on the guidelines provided by the University of
Nebraska-Lincoln. All references have been provided at the end of this thesis.
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Chapter 2
Related Work and Background
2.1 Outline
This thesis is intended for readers from a wide range of backgrounds, especially
those in the biological and computational sciences. As part of Chapter 2, we provide a
comprehensive overview of prior works that have used Machine Learning and Deep
Learning techniques integrated with metabolomics pipelines. Following a brief
background, we outline our motivation by first bringing forward some caveats in
existing works and then addressing them through our approach, thus defining our
objectives. Lastly, we elaborate on some concepts to make sure that the reader
understands specific terminologies, frameworks, and equations used throughout this
thesis.

2.2 Background
Machine Learning (ML) is a field of computer science and mathematics that deals
with algorithmic and statistical techniques for modeling and analyzing data [17]. The
subject is closely related to the study of artificial intelligence (AI), though ML does not
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always have a clear distinction between these two areas. In recent years, ML has turned
out to be a vital tool in elevating flux analysis in GEMMs and helping understand
environmental factors that affect cell phenotypes [18]. Giuseppe et al. estimated the
production of lactate in Chinese Hamster Ovary (CHO) cells using linear regression on
gene expression profiles [19]. Wu et al. could predict fluxomics of heterophobic bacteria
based on their kind, types of substrate, aerobic/anaerobic conditions, and cultivation
methods using an ensemble of ML methods, namely SVM, k-NN, and Decision Trees
[20]. Folch-Fortuny et al. applied an unsupervised approach named Multivariate Curve
Resolution - Alternating Least Squares (MCR-ALS) to offer a more meaningful
representation of metabolic pathways in P. pastoris [21]. Szapannos et al. [22] used
genetic algorithms to help improve the prediction of gene-gene interaction networks to
bridge the gap between empirical and computational studies in yeast metabolism.
Deep Learning (DL) refers to a subset of ML and AI [23]. It is particularly
concerned with large Artificial Neural Networks (ANNs). The primary idea is that
intelligence can be expressed as a set of layers, with each layer using the output from the
previous layer to produce its next output. DL has been successful in a variety of
non-linear problems and unstructured data, especially wherein ANNs help identify such
important features and patterns in data [24]. The ability to find these patterns means DL
can be applied to many different industries, including finance, health care, and even
biological engineering [25].
ANNs are inspired by the human brain, and their structure is similar to that of
human neurons [26]. Each neuron within the ANN constitutes a predefined activation
function that translates the incoming input from each layer to an output signal strength
that validates the input. The larger the scale of the network in terms of the number of
neurons and layers, the "deeper" the network is. Such deep networks can be configured
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for a wide range of tasks ranging from speech recognition, object classification on
images, and text translation [27]. Due to the availability of high-throughput
multi-omics data in modern biology, the data boom has also paved the way for
integrating data reduction, selection, and translation tasks in systems biology with
Machine and Deep Learning [28].
There have been a limited number of papers involved in the integration of Deep
Learning and Systems Biology, especially in the area of Genome-Scale Metabolic Models
(GEMMs) that use a kind of learning technique called Autoencoders (AE). AEs are a type
of deep learning that is self-learning

[29]. They can encode data into an efficient

representation without any human intervention. In the last few years, autoencoders
have produced significant results in image and speech recognition and in the process of
machine translation [30]. As an example, Guo et al. [31] consider an approach titled
‘DeepMetabolism’ which consists of a 5-layered AE wherein the first 2 layers of the
network are connected by Gene-Protein Rules (GPR) annotated within a GEMM model
offered in SBML format [32]. Statistical simulations from Flux Balance Analysis (FBA)
were used to connect the 3rd and 4th layers of the autoencoder network. Using
experimentally measured transcriptomic profiles, the decoding layers of the AE were
then expected to reconstruct phenotypic relationships from its genotype with very high
accuracy.
Variational Autoencoders (VAE) are a type of Deep Learning technique that has
been known to be successful in generating new and unseen data which closely resembles
the original input [33]. They work by encoding such data into a latent vector which is
then used to generate new unseen data within the same distribution using an
encoder-decoder network. In their approach, Barsacchi et al. [34] used a paradigm
dubbed GEESE (Gene Expression latEnt Space Encoder) that uses a β-VAE architecture to

19

relate gene expression profiles to the regulation of reaction fluxes by generating
synthetic gene expression data.

2.3 Motivation
In this thesis, we thoroughly examine and build upon prior works of integrating
Machine and Deep-Learning-based methods to experimentally generate GEMMs
emulators and validate whether the proposed approach is both effective and efficient in
terms of introducing it within metabolic engineering analysis pipelines. Even though
Barsacchi et. al [34] works have introduced the possibility of such an approach, almost
all prior works rely on a multi-omics strategy by introducing at least some form of
experimentally conducted knowledge generated within laboratory experiments (gene
expressions, transcriptomic profiles, etc.). Thus, the need for such experimental data
limits the overall scope of expansion of such approaches to GEMMs for other organisms
or cell types. In addition, steps to perform a systematic comparison of Deep
Learning-based methods with other approaches have not been taken in the case of
leveraging FBA. Moreover, advanced modeling approaches in Deep Learning have risen
exponentially in recent years with the introduction of new and updated sophisticated
networks that significantly overcome many drawbacks (training time, better data
representation, etc.) of its predecessor networks [35]. In this thesis, we consider using a
Wasserstein Conditional Generative Adversarial Network (with Gradient Penalty)
(WCGAN-GP)-based approach [36] by using pure synthetic data generated using Monte
Carlo simulations from reconstructed GEMMs available in standardized formats. This
eradicates the need for additional multi-omics data by only using the refined truth
embedded within gene-protein reaction (GPR) links available within the annotated
model of interest. Conditional Generative Adversarial Networks (CGANs) have recently
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been shown to be powerful semi-supervised alternatives to regression modeling
techniques and generate novel data points [37]. To the best of our knowledge, this work
would be the first to utilize WCGAN-GP as an alternative to standard regression models
and validate its usage for even other regression-based problems.
The primary objective of such an approach is to
1.

Validate whether such a ‘black-box’ model is capable of generating unseen
genotype-phenotype relationships.

2. Reduce the computational time to perform FBA (by initially training the network
with a considerable amount of data points in a constraint space subset).
3. Produce

possible

feasible

solutions for constraints that were initially

thermodynamically unfeasible.
To compare our approach, we consider a popular regression-based machine
learning technique - Linear Regression [38] concerning a WCGAN-GP-based approach.
Each method has its own learning and prediction times that are considered evaluation
variables

for

our

comparisons.

At

the

same

time,

we

also

compare

our

WCGAN-GP-based approach across 3 GEMMs representing different organisms in
nature - ranging from non-pathogenic prokaryotes to parasites to organisms of varying
sizes (as observed in nature).
To keep compliance with FAIR research [39], we implement a high-throughput
pipeline named ‘DeepGEMM’ using a customized self-implemented version of cobrapy
[40] and the standard off-the-shelf available Deep Learning library - TensorFlow [41]
as governing frameworks for reproducible analysis of this work and recreation of
DL-based GEMM emulators. Our implementation of the DL pipeline is written in the
Python language with ‘convention over configuration’ in mind. The choice of language
and frameworks was based on using only the most recently advanced methods, ease of
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use, and widely-available access, as well as the interpretability of software across all
platforms. In terms of training and analysis, we use the Holland Computing Center’s
high-performance computing resources offered at the University of Nebraska-Lincoln
to generate synthetic datasets and learning weights of the model emulators. This was
done to ensure a standardized comparison across all methods concerning the proposed
WCGAN-GP-based model.

2.4 Genome-Scale Metabolic Models
Synthetic Biology is a science that seeks to design and create new organisms and
synthetic pathways by manipulating genomes resulting in new phenotypes [42]. In their
eight-year-long project, Beyer et. al published their scientific insights into - the Golden
Rice, created by introducing the

β-carotene (a vitamin A precursor) biosynthetic

pathway into Oryza sativa (traditional Asian Rice) [43]. Mehta et al. helped improve the
juice quality, vine life, and lycopene in tomatoes [44] by using genetic modifications
that resulted in an increase in polyamine, spermidine, and spermine accumulation
during ripening. Systems Biology has the potential to reimagine how biologists design
and apply genetic mutations in silico, leading to the discovery of new biological
phenomena without the need to conduct experiments in vivo [45]. The domain consists
of various mathematical and computational frameworks for modeling, simulation, and
analysis of various biological systems, be it uni-, multicellular, or even a community of
organisms interacting within an environment. Systems Biology has heavy applications
in a variety of problems, such as cancer research and drug development [46]. In this
thesis, we focus on a particular kind of computational modeling technique in Systems
Biology that deals with the metabolism of biological systems called Genome-Scale
Metabolic Models (GEMMs). Genome-Scale Metabolic Models (GEMMs) are a powerful
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tool for understanding the metabolism within organisms and the fundamental processes
and relationships that allow cells to grow, divide, and produce energy [47].
Note that such models are larger in size and can often contain more than
thousands

of

species,

reactions,

and

enzyme

information

for

even

small

micro-organisms [10]. To reconstruct an organism of interest to its genome-scale,
several algorithms have been developed to provide a well-curated reconstructed draft to
a refined level of detail by extracting annotated genes from raw RNA sequence data [48]
[49]. While we assume the availability of a well-reconstructed GEMM during our
analysis, the work done within this thesis is not limited to the same. In the following
section, we elaborate on the mathematical framework governing GEMMs - Flux Balance
Analysis.

Figure 2.1 Genome-Scale Metabolic Model reconstruction of Z mobilis. and analysis using a classical
metabolic engineering pipeline. (Source - [50])
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2.5 Flux Balance Analysis
Flux Balance Analysis (FBA) is a well-known technique for modeling the
metabolism of living systems. It is used to understand and predict the levels of metabolic
intermediates, enzyme activity, and fluxes [5]. In this technique, constraints are
imposed on a model to reduce the number of free parameters and also constrain the
model to be consistent with experimental data. FBA then uses mathematical
optimization frameworks that use linear equations to help maximize the growth of
living cell populations [3].
As a result, such a technique helps modelers explore and understand the effects
of small changes in nutrient concentration or other factors on the rapid growth of cells
[51]. In this thesis, we are interested in devising a surrogate model for a given organism
that is also capable of approximating growth rates within the organism subjected to
certain environmental conditions by substituting a traditional FBA framework with a
Deep Learning surrogate. The objective is not to completely replace traditional FBA but
rather elevate the overall process of modeling biochemical metabolic pathways and, at
the same time, effectively reduce computational costs.
At the core of FBA

is a mathematical representation of the Genome-Scale

Metabolic Model (GEMM) in a matrix format, often called the Stoichiometric Matrix (S)
[52]. S represents the stoichiometry of each biochemical reaction interacting within the
biochemical network of an organism. Generally, the stoichiometric matrix of a typical
GEMM can be represented as follows:
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Here,

it represents the

network.

and

th

metabolite and the

th

reaction in the metabolic

represents the cardinality of the metabolite and reaction sets

respectively. Typically, the stoichiometric matrix of even the smallest of all organisms
would be represented as a sparse matrix. In fact, the GEMM reconstruction of the
smallest genome available - M. genitalium (iPS189) - consists of at least 274 metabolites
and 262 reactions [53]. In addition, a GEMM also consists of a set of Gene-Protein
Reactions (GPR) rules that can be represented by independent regulatory networks
determining the potential activation states of reactions associated with it. Gene-Protein
Reaction (GPR) rules represent the possibility of a reaction to achieve metabolism based
on proteins produced by an organism, i.e., the effect of a gene on growth rates of
metabolic reactions [5].
A GEMM consists of an objective function (or many) to be either maximized or
minimized. In a biological sense, this is typically associated with the maximization of a
biotechnologically important metabolite or reaction or minimizing its nutrient uptake.
For most organisms, the primary objective for survival is to maximize their biomass
production [54]. This is achieved by breaking down external compounds (oxygen, sugar,
etc.) to multiply. Hence, one can derive a set of system equations from a GEMM
containing a considerable number of distinct variables and a set of ordinary differential
equations (ODEs). These equations represent the rate at which a chemical reaction
occurs within the biochemical pathways of the organism, subject to a vast number of
constraints. Ideally, the state of the system can be defined as follows:
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Here,

represents the growth rate of a chemical reaction (or simply, the metabolic

flux), whereas here,

represents the concentration of a metabolite .

and

represent the lower and upper bounds of the solution space. Notice that the vector

has

been transposed to fit the equation correctly.

The flux through a chemical reaction is generally expressed as
is millimole,

where

which is the dry weight of the organism. In the case wherein

the objective is to maximize biomass production, we are specifically interested in the

doubling rate of the organism. Hence, the unit for the same can be expressed as
, where

represents the organism’s doubling rate per hour. Flux Balance Analysis

assumes a Pseudo Steady State Hypothesis (PSSH) of the biological system [56], i.e., it
assumes that the concentration of each metabolite does not change over time, thus
eliminating information related to enzyme kinetics. Therefore, the system can be
minimized as a set of pure linear equations as follows:
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We narrow down the system as a pure mixed integer linear programming (MILP)
problem subjected to other constraints (in a biological sense, this generally relates to
either limiting the growth rate of reactions or important nutrients). Figure 2.2 denotes
the narrowing of the convex polytope solution space based on constraints imposed. In
the case of biological systems subject to a large number of chemical reactions, such a
polytope is hard to visualize in an

dimensional space.

The applications of Flux Balance Analysis in Systems Biology have been endless.
Japhalekar et. al. were able to use FBA as a means to prove the overproduction of organic
acids in Cyanobacteria (Synechocystis sp. PCC 6803) in dark anoxic conditions [56].

Figure 2.2 Narrowing Solution Space due to constraints imposed by metabolic reaction bounds
in Flux Balance Analysis (Source - [5])

Da Veiga Moreira et al. were capable of optimizing citrate overproduction in yeast
(Yarrowia liplytica - iYali4) using dynamic Flux Balance Analysis (an extension to FBA)
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[57]. There is therefore no doubt that Flux Balance Analysis (FBA) has been a vital tool in
Systems Biology having a wide range of applications [58]. In the next section, we will
elaborate on the Deep Learning methodology used to help us build GEMMs emulators for
organisms.

2.6 Wasserstein Conditional GANs (with Gradient Penalty)
Generative Adversarial Networks (GANs) are a class of Deep Learning algorithms
that can create new unseen or modified data points by learning low dimensional
representations of an input dataset. These neural networks use two deep learning
models: a generative model that creates data and a discriminative model that evaluates
data created by the generative network [59]. GANs have recently made tremendous
progress in the field of bioinformatics, ranging from medical image analysis and
processing to the realistic generation of single-cell RNAseq data [60]. Ghahramani et. al.
were able to use a WGAN-GP to achieve a universal representation of the Epidermal
Differentiation Complex (EDC) and predict cell state perturbations on gene expression
profiles [61]. Recently, Cao et. al. used string-based Simplified Molecular-Input Line
Entry System (SMILES) representations of compounds as input data into a GAN that
generates new unknown valid molecules [62].
Traditionally, the two feed-forward neural networks act against each other like a
zero-sum non-competitive minimax game to minimize the independent errors fed back
into the network for learning. Ideally, the objective of a generator
discriminator

by offering fake samples, whereas the objective of the discriminator is

to not be cheated during its critiquing process. If
data distribution over
by maximizing

is to trick the

represents a real sample and

, then the critical decision made by
. In the case of a fake sample

over

is the

must be accurate

over an input noise ,
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the discriminator must estimate a probability

, closer to zero by maximizing

. Hence, the overall loss function to be optimized by the GAN
would be:

Note that the term

does not cater to the generator during

training. Due to this, GANs generally suffer from convergence instability as they attempt
to find the Nash Equilibrium during convergence. This generally occurs when the
distributions

and

are disjointed from each other.

2.6.1 Wasserstein Metric and K-Lipschitz Continuity
Movement from one distribution to the other can be intuitively thought of as
moving a unit of dirt from the earth from one pile to the other. Therefore, the minimum
energy cost it takes to transfer such a pile can be thought of as the distance between
these distributions where the cost would be the amount of dirt moved times the mean
distance between the piles. In the case of our GAN, the Wasserstein Metric between the
data distributions

Here,
between

and

is given as follows:

represents a set of all possible joint probability distributions
and

. Arjovsky et. al [63] provides a modified formula to the above

equation to compute the distance between discrete distributions as follows:
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Here,

is the supremum (opposite to

, the infimum).

is expected to satisfy the

term to be K-Lipschitz continuous.

2.6.2 Wasserstein Loss Function
The GAN’s discriminator is now trained to learn a K-Lipschitz continuous
function to calculate the Wasserstein distance between the real and fake sample
distributions. With a decrease in discriminator loss, the generator is then expected to
produce fake samples closer to the actual distribution of the input dataset. If

is a

K-Lipschitz

the

continuous

function

discriminator is expected to learn

subjected

to

parameters

in order to find the best fit for

,

then

with a loss

function as follows:

The weights are then clipped within a pre-defined bounded region in order to
enforce K-Lipschitz continuity of the function

. However, this might be a poor

approach towards restricting the function from being K-Lipschitz continuous. To
overcome this, Gulrajani et. al offered an alternative solution by penalizing the gradient
weights during the training process. On doing so, it promises a faster means for
convergence of the two distributions being within proximity [36].
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Figure 2.3 Wasserstein Conditional GAN Architecture for DeepGEMM

2.6.3 Conditional GANs
Conditional Generative Adversarial Networks (CGANs) are a type of GAN that can
generate data conditioned on an input. The idea of CGANs is to have a generator model
that outputs fake data given some signal and a discriminator model that tells the
generator whether its output is real or fake based on that signal. Conditional GANs are
considered to be a kind of semi-supervised learning approach since both the networks
are conditioned to generate input closely resembling the one provided. We utilize this
crucial feature of Conditional GANs to help the learning model approximate the flux
value of a reaction based on input constraints. Figure 2.3 shows an architecture diagram
of the proposed WCGAN-GP network with respect to our flux predictor.
In the next section, we provide a detailed outline of the proposed pipeline to
output model surrogates of the input metabolism. We also exploit the network
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characteristics of the input GEMM to minimize the number of feature dimensions
required during GAN training and evaluate the validity of our approach in detail.
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Chapter 3
Approach
3.1 Outline
In our approach, we first define our problem at hand and then outline an
overview of the various modules that constitute our pipeline. Next, we describe how
Monte Carlo sampling was used to create a synthetic dataset to be fed into our deep
generative model. Following that, we use the original input metabolic network and
consider the idea of dimensionality reduction through the minimization of its reactome.
Finally, we outline the internal workings and configuration (hyperparameters and
training) of our WCGAN-GP network.

3.2 Problem Definition
The main problem that we aim to resolve in this research is defined as follows:
Given a Genome-Scale Metabolic Model (GEMM) of an organism
,

is a set of metabolites,

is a set of reactions and

, where

represents

is a set of boolean-based

gene-protein reaction (GPR) rules, train a Deep Generative Model to predict the corresponding
flux distribution of

(say

) by minimizing the error loss from its actual flux distribution
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of

and at the same time, performing it efficiently in terms of computational time and

resource utilization.

3.3 Pipeline Overview
Our DeepGEMM pipeline can be bifurcated into different modules as follows:
●

Synthetic Data Generation: A Monte Carlo sampling of the convex polytope
hyperspace was considered to generate reaction flux distributions of the input
metabolic network across various constraints.

●

Dimensionality Reduction (minimization of network): We reduce the genome-scale
metabolic network to a minimal network by removing non-functional metabolic
reactions that do not hinder target growth conditions yet maintaining the overall
functionality of the base network.

●

Parameterization and Training: We format our WCGAN-GP network corresponding to
the dimensionality of the reduced metabolic network, feeding in our synthetic data
for eventual training of our conditional GAN and its hyper-parameterization,
thereby attempting to minimize the loss between the original flux distribution and
the reaction fluxes generated from the GAN network.

3.4 Synthetic Data Generation
We propose a methodology to synthetically generate reaction flux distributions
subjected to different kinds of model mutations and constraint limitations. Figure 3.1
illustrates the detailed workflow of generating such a synthetic dataset. In this
approach, a Monte Carlo scheme of flux sampling random points from the solution
space was considered as sample data points for the dataset.
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Figure 3.1 Monte Carlo Flux Sampling for Synthetic Data Generation of a given Metabolic Network
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Monte Carlo simulations of the effective solution space of a GEMM has proven to
be a useful approach in extracting important properties of the metabolic network - like
the hypervolume of the convex polytope flux distribution space [64], topological and
subsystem information of the network [65], thereby remaining robust to variations in
constraints.
Given

(the number of sample points to be generated), we first consider an

input metabolic model from a model repository (BiGG, BioModels, EMBL GEMs, etc.).
[66] [67] [48] and randomly (uniformly) pick a mutation strategy to be applied to the
model.

Note

that

throughout

the

course

of

performing

mutations

or

constraint-restrictions, unless undefined, we consider the pseudo reaction - wild-type
biomass

to

be

the

defined

objective

for

the

input

organism.

The

mutation/constraint-limitation strategies devised for this approach are as follows:
1.

Reaction knockout (Mutation): An in silico reaction knockout is achieved by

limiting the growth rate bounds to 0

of the reaction in the metabolic

network. Under in vivo conditions, it is feasible to perform up to triple reaction
knockouts for a given organism [68]. Thus, we consider random subsampling
(uniform) of up to 3 reactions in this stage that performs a single, double or
triple knockout analysis.
2. Gene knockout (Mutation): Similar to the approach mentioned in 1., we subsample
up to three genes (random uniform) that perform a single or multi-knockout
mutagenic

simulation.

A

metabolic

network

generally

contains

gene-protein-reaction links as regulatory rules which indicate the relations
between activation states of gene products and the corresponding enzyme
catalyzation of reactions. Gene knockout mutations also offer Gene Coupling
(dependence of the activation state of a single gene affects multiple reactions
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across the metabolic pathway), information regarding essential genes and
genetic robustness of the organism [69] [70].
3.

Altering Reaction Bounds (Constraint-Alterations): In the biological sense,
alteration of reaction constraints typically correspond to altering growth
conditions of reactions or nutrient uptake. We consider subsampling (randomly
uniform) a subset of reactions and alter its lower and upper bounds (random
uniform) within the range:

●

-1000

●

0

and 1000

and 1000

if the reaction is reversible.

otherwise.

The artificially induced ranges generally cover the diffusion limits for many
reactions since the diffusion rates for even the largest metabolites are approximately
100

.
We consider the dataset to comprise both natural and perturbed state

information of the organism of interest [71]. Such mutation strategies are also viable to
infer the minimization of metabolic adjustments (MOMA) required for the organism to
survive and grow, thereby providing a diverse representation of the flux distribution
cone within our dataset. We perform an FBA over the perturbed/altered metabolic model
and predict the uptake rates of all reactions within the network using Linear
Programming (LP). A simulation is considered successful with a sample point generated
if the solution is feasible else it is disregarded from the synthetic dataset. Finally, a
sample point consists of the lower and upper bounds of each reaction, the mutation
strategy used to generate the corresponding flux distribution, and the solution fluxes
itself, based on the constraints imposed through such mutation. The matrix dimensions
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of the resultant dataset is

where

denotes the cardinality of the reaction

set of the input metabolic network.
We implement our synthetic data generator script in Python and parallelly
perform perturbations for each strategy. For a sample model, e_coli_core comprising
72 metabolites and 95 reactions, the average time it took to generate 1 million sample
points with 8 processors was approximately 9 hours. Figure 3.2 visualizes a plot between
the size (metabolites and reactions) of 1213 GEMM networks over the time it takes to
generate 1000 feasible synthetic data points.

Figure 3.2 Synthetic Data Generation of 1213 GEMMs over Time (seconds) (1000 samples)

The networks were randomly selected from a large collection of GEMMs available
from various model repositories. As a result, we conclude that the size of an annotated
GEMM network, and the time necessary to generate feasible sample points follow a
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linear relationship. This is natively trivial since larger networks contain sparser matrices
to derive possible solutions.
Similarly, much can be said about the number of infeasible solutions generated
using our Synthetic Data Generator with respect to the size of the metabolic network.
Figure 3.3 visualizes the relationship between the size (reactions and genes) of 1213
GEMM networks over the number of infeasible solutions generated when

.

Figure 3.3 Number of Infeasible Solutions of 1213 GEMMs w.r.t. size of the network (1000 samples)

Based on our above plot, we observe the following:
●

A tiny concentrated purple cluster towards the right of the large blob indicates
the different strains of annotated E. coli by generating infeasible solutions
through

these

strains.

Thus,

we

conclude

that

random
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mutations/constraint-limitations generated by our Monte Carlo simulations that
cause lethal damage to organisms are generally consistent.
●

Also, there is an inverse correlation between the number of infeasible solutions
and the size of the network (particularly with respect to the number of reactions
annotated within the model). This indicates that synthetic lethal damages to the
network or performing any form of constraint restrictions limits the organism to
opt for alternate pathways in order to survive. Furthermore, we observe that
larger metabolic networks contain a large number of non-essential genes and
reactions (since the number of infeasible solutions generated is lower even with a
consistent number of random reaction-gene-knockouts or limiting flux
boundaries).

●

Chinese Hamster (iCHOv1_DG44), Common House Mouse (iMM1415) and the
Phaeodactylum tricornutum (iLb1027_lipid) hold low survival rates even with
sufficient mutations and a large annotated model.
In the next section, we consider the idea of dimensionality reduction using

reactome minimization of the metabolic network.

3.5 Reactome Minimization
Dimensionality Reduction is the idea of reducing the number of dimensions
within a dataset to reduce complexity, for instance by converting
vectors

into

-dimensional

vectors.

In

Genome-Scale

-dimensional

Metabolic

Models,

dimensionality refers to the size of the metabolic network in terms of the number of
metabolites, reactions, and genes annotated within it.
The presence of a considerable amount of functional redundancy has been
well-studied in the case of GEMMs. For instance, about 37-47% of reactions within the
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metabolic networks of E. coli and yeast can be removed without hindering the organism's
growth rate under any environment [72]. Even after multiple genetic variations,
evolution has helped many organisms to consider alternative pathways in order to
sustain lethal damage and maintain survivability [73] [74]. Almaas et. al. identified the
existence of a metabolic core consisting of active reactions that have highly correlated
flux variations irrespective of the growth conditions within the model [75].
Burgard et. al. were the first to identify a method to find the minimal reactome in
an E. coli metabolic network [76] using a MILP approach. In addition, there are other
approaches that take advantage of the characteristics of the underlying structure of the
GEMM network. For instance, Jonnalagadda et. al used a graph-theory + MILP-based
approach to reduce an organism’s GEMM to a minimal required metabolism [77].
Recently, Lugar et. al was capable of utilizing matrix manipulation of the sparse
stoichiometric matrix as an alternative to find a minimal reactome [78].
For our approach, we utilize the MinREACT algorithm offered by Sambamoorthy
et al. [79] and study it in detail with respect to our pipeline. Unlike other approaches, the
MinREACT algorithm leverages the very structure of the network by analyzing the
reaction classes identified by performing a parsimonious FBA [80]. The MinREACT
algorithm also results in a smaller reactome of the input metabolic network as compared
to other prior approaches.
As an example, we perform the MinREACT algorithm on 50 GEMMs chosen
randomly from each model repository. Figure 3.4 visualizes a plot between the size
(metabolites and reactions) of 50 GEMM networks over the time it takes to produce a
minimal reactome.
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Figure 3.4 Minimal Reactome Generation (using MinREACT) of 50 GEMMs over Time (seconds)

Evidently, the network size increases the overall execution time of the
MinREACT algorithm exponentially, directly correlating to the time it takes to achieve
‘single lethals’ (single reaction deletions) that ought to be discarded from the network.
There also exists a metabolic core for almost all tested GEMMs that contains up to 1000
reactions within the compressed network irrespective of the size of the original input
graph. Figure 3.5 confirms the above statement by depicting the size of the input
metabolic network (metabolites and reactions) with respect to the number of reactions
in its minimal reactome.
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Figure 3.5 Number of reactions within the minimized network w.r.t. size of original network (50 GEMs)
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Chapter 4
Results and Analysis
4.1 Outline
The experiments conducted for our results and analysis evaluate across multiple
dimensions to answer many research-related questions. For our first dimension, we
consider a comparative study of different models chosen based on time, accuracy, and
feasibility. The next dimension considers a breadth-based analysis of the composition
and nature of our input dataset based on our model choice. Finally, the third dimension
caters to the effects of various hyperparameters introduced into our workflow pipeline.
As mentioned, we consider a comparative evaluation across 3 well-annotated GEMMs
namely - e_coli_core (E. coli), iIS312_Amastigote (Trypanosoma cruzi), and iAB_RBC_283
(Homo sapiens).

4.2 Configuration
To

ensure

unbiased

comparison,

we

consider

universally

predefined

hyperparameters across all our learning models. The Adam optimizer [81] was our
primary choice for performing gradient-based optimization with a constant learning
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rate of 0.001. For all our deep networks, we place a dropout layer after each dense hidden
layer with a penalty rate of 0.2 (i.e., we penalize the weights of 20% of neurons in the
preceding layer during training). This is to ensure that our models attempt to generalize
well and avoid suffering from overfitting our synthetic dataset [82]. To ensure that the
model achieves a neat yet diverse overview of the solution space, we consider a K-Fold
cross-validation of 20% of the training set per epoch. We also consider performing an
early stopping during training when the

(coefficient of determination) of our

validation set does not change after 10 epochs (training iteration) by a factor of 0.01;
50-100 epochs otherwise. We generate a dataset of over 1 million observations for each
of our organisms and split each dataset into 80%-20% training-testing sets
respectively. Prior to training, we normalize both the reaction bounds and the flux rates
within the range [0, 1] as a preprocessing step. To avoid overfitting, we consider feeding
our learning models a batch of our dataset (512 samples) during a forward feed.
In the case of our global states, we use MAE (Mean Absolute Error) as our global
loss function across all gradient-based learning models (since MAE is a lot less sensitive
towards outliers than estimating the Mean-Squared Errors). The MAE of an actual
versus the predicted flux can be given as follows:

Here,

rate in

represents the predicted flux value of reaction

whereas

represents its actual

. In the case of our WCGAN-GP-based model, we use the cumulative losses

collected from the individual generator and discriminator losses.
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4.3 A DL emulator for Escherichia coli strain K-12
substrain MG1655 in silico
Escherichia coli is a genus of Gram-negative, rod-shaped bacteria that are mainly
found in the lower intestine of warm-blooded organisms. E. coli can be pathogenic and
cause disease by producing Shiga toxin, causing colitis and hemolytic uremic syndrome,
and by contributing to the development of hemorrhagic fever with renal syndrome. The
E. coli MG1655 has been a well-studied genome with a well-curated Genome-Scale
Metabolic Model which will be used as our test organism for analyzing our pipeline [83].
To explain in depth our approach, we consider the wild-type E. coli str. K-12 substrain
MG1655 genome-scale metabolic model [84] as a case study to run through our pipeline.

4.3.1 Baseline Model
In predicting biomass growth rate within an in silico E. coli GEMM, we consider
Linear Regression as our initial model to benchmark our performance. Our Linear
Regression model can be considered a simplified version of the McCulloch-Pitts Neuron
[26] model with no activation function. Figure 4.1. Illustrates the layer configuration of
our Linear Regression model. Note, the DenseBlock layer denotes an intermediate layer
containing 190 neurons and 1 unit worth of a bias neuron.

Figure 4.1 Model Configuration of our Linear Regression Model for e_coli_core
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Even with its limitations, Simple Linear Regression performs well with a testing
score of 0.7715 in the case when the input dataset comprises information associated
with only the perturbed state of the GEMM model. We also noticed an early stopping at
around 37 epochs. We achieved a validation loss of MAE of 0.0543 and an MSE of 0.0302
respectively. The average training time up to 38 epochs was 12.27 minutes, a
comparatively impressive Time-to-Train (ToT) as compared to other learning-based
models.
Figure 4.2 illustrates the actual versus predicted growth rates for the biomass
objective in an E. coli GEMM specifically associated with the lethally damaged states of
the model. A good reason as to why our baseline model works well in the case of
predicting perturbed states is due to the fact that a GEMM model of small size generally
lacks more insights into the organism’s metabolic states, therefore stunting growth
quicker than a well-annotated model.

Figure 4.2 Actual versus Predicted flux rates of the biomass objective in E. coli. GEMM
(perturbed, baseline)
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In continuation, we consider predicting the objective based on the healthy state
of the input organism. Our baseline model took up to 46 epochs with a quicker training
time clocking at 8.36 minutes. However, the testing

score stabilized at only 0.3795. A

validation loss of 0.0485 (MAE) and 0.0159 (MSE) were achieved respectively. Figures 4.3
and 4.4 visualizes the training and validation losses and an improving

score over

each epoch for our healthy (with restricted nutrient uptake), perturbed, and combined
model.

Figure 4.3 Training and Validation Losses (baseline)
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Figure 4.4 Coefficient of Determination scores (baseline)

In terms of the actual versus predicted growth rates for our objective
pseudo-reaction, the model shows a relatively linear trend in Figure 4.5. For the sake of
clarity, we visualize only 10,000 randomly chosen samples from our testing set
containing 200,000 samples.
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Figure 4.5 Actual versus Predicted flux rates of the biomass objective in E. coli. GEMM
(healthy, baseline)

We combine both the healthy and perturbed states of the organism as our input
dataset to check whether the lethally damaged states of the model penalize the
capabilities of function approximation by our learning model. Our learning models can
distinguish a healthy versus a perturbed state of the GEMM with a testing

score of

0.3938. However, no early stopping was observed with the model completing within 50
epochs and with a validation loss of 0.0227 (MAE) and 0.00535 (MSE). Figure 4.6
visualizes the actual versus predicted flux in the case of the biomass pseudo reaction as
our objective function.
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Figure 4.6 Actual versus Predicted flux rates of the biomass objective in E. coli. GEMM
(overall, baseline)

4.3.2 WCGAN-GP Model
The WCGAN-GP-based model achieves a testing

score of 0.9558 in just 14

epochs by helping predict the corresponding objective flux based on synthetic lethal
reactions and gene knockouts. Clearly, our DL approach stands out learning essential
from non-essential gene sets by observing the probability distribution of the flux vector
cone. A validation loss of 0.0221 (GAN loss) was achieved by our model. Figures 4.7 and
4.8 visualizes the training and validation losses and improving

scores over each

epoch for our WCGAN-GP-based approach. Both, training and validation losses for each
of our models drop significantly within 10 epochs worth of training with a gradual and
smooth increase in its coefficient of determination. However, our DL approach tends to
be slower in terms of training time as compared to our baseline model by an average
factor of 3 clocking at 30 minutes (average) until halt.
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Figure 4.7 Training and Validation Losses (WCGAN-GP)

Figure 4.8 Coefficient of Determination scores (WCGAN-GP)

On combining both the healthy and perturbed states of the organism as our input
dataset, our DL model achieves an

score of 0.7335 on the testing set and a validation

loss of 0.01536 halting at 32 epochs. Figure 4.9 represents the best fit estimation of
predicted fluxes of

of the E. coli GEMM.
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Figure 4.9 Actual versus Predicted flux rates of the biomass objective in E. coli. GEMM
(healthy, WCGAN-GP)

Evidently, the plot follows a higher degree of linearity as compared to our
baseline model. A noteworthy limitation within FBA’s SIMPLEX approach is that it is
generally hard to estimate whether a combination of given constraints leads to
multi-optimal states of growth within the model and if so, the values of all possible sets
of values of such states. This also holds true in the case of our DL-based pipeline when
unaware of whether a prediction is part of a multi-optimal solution set. Figure 4.10
represents the best fit estimation of predicted fluxes of

of the E. coli GEMM for

our complete input dataset. This relationship portrays the capability of our DL model to
approximate biologically relevant growth estimates based on different and distinct
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distributions of the convex polytope solution space. It offers a linear relationship trend
between the actual versus predicted flux values irrespective of the model state.

Figure 4.10 Actual versus Predicted flux rates of the biomass objective in E. coli. GEMM
(overall, WCGAN-GP)
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4.4 DL emulators for Trypanosoma cruzi and Homo
sapiens in silico
For general-purpose use-cases, we consider two additional well-curated GEMMs
iIS312_Amastigote and

iAB_RBC_283 and evaluate each of them with respect to our

DL-based pipeline.
Trypanosoma cruzi is a parasite that causes Chagas disease. The parasite lives in
the blood, heart, and digestive tract of an infected person. It is transmitted by the bite of
an infected bug called a “kissing bug”. The most common symptoms of Chagas disease
are fever, fatigue, body aches, or swelling around the bite wound. The infection can
cause serious complications such as heart disease and intestinal inflammation that can
lead to death. Interestingly, this parasite is also a well-studied organism in the sphere of
metabolic engineering [85] [86] [87].
We use a similar configuration of the DL pipeline as described in Section 4.2.
However, the metabolic network is significantly larger as compared to our previous
study with 609 metabolites and 519 reactions. To reduce its dimensionality, we perform
a reactome minimization of the network by knocking out the set of reactions that are not
part of the minimized network. On performing the MinREACT algorithm over
iIS312_Amastigote, we get a minimized reactome containing 89 biologically relevant
reactions. Our input data feed is then a subset corresponding to this minimized reaction
set of the network. To improve training time, we use transfer learning [88] by using
trained weights on the diseased state with other types. This encourages a quicker
learning curve since adjustments to the hyperspace of the convex polytope has been
viewed before by the learning model. Unlike E. coli., the parasitic GEMM shows an inverse
trend with respect to learning our input dataset.
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Figure 4.11 Training and Validation Losses (iIS312_Amastigote, WCGAN-GP)

Figure 4.12 Coefficient of Determination scores (iIS312_Amastigote, WCGAN-GP)

Figures 4.11 and 4.12 visualizes the training and validation losses and improving
scores over each epoch for our WCGAN-GP-based approach in the case of
iIS312_Amastigote genome. We achieve a relative

score of approximately 0.6 for all

our data types at an average of 40 epochs. Interestingly, our diseased model states
perform poorer as compared to a normal counterpart. Another interesting thing to
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notice is that our learning models are capable of estimating the flux cone’s outer
boundaries. Figure 4.13 represents the best fit estimation of predicted fluxes of
of Trypanosoma cruzi.

Figure 4.13 Actual versus Predicted flux rates of the biomass objective iIS312_Amastigote in GEMM
(overall, WCGAN-GP)

In the case of our Homo sapiens (iAB_RBC_283) model, we minimize the reactome
from 342 metabolites and 469 reactions to a metabolic core consisting of 71 reactions.
Generally, the target objective in the case of humans (primarily in the case of animal cell
neurons) is the transportation of Na+/K+-ATPase across the cell membrane. Figures
4.14. and 4.15. visualizes the training and validation losses and improving

scores over

each epoch for our WCGAN-GP-based approach in the case of iAB_RBC_283 GEMM.
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Figure 4.14 Training and Validation Losses (iAB_RBC_283, WCGAN-GP)

Figure 4.15 Coefficient of Determination scores (iAB_RBC_283, WCGAN-GP)

Impressively, iAB_RBC_283 achieves with a testing

score of 0.8615 for

perturbed-based predictions. This is promising since the parameterized model is
capable of learning the gene lethality of the input organism. On combining both the
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healthy and perturbed states of the organism as our input dataset, our DL model
achieves an

score of 0.6240 on the testing set and a validation loss of 0.0295 halting

at 78 epochs. Figure 4.16 represents the best fit estimation of predicted fluxes of
for the Homo sapiens GEMM.

Figure 4.16 Actual versus Predicted flux rates of iAB_RBC_283 - Na+/K+ ATPase
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4.5 Computational Efficiency
While the time taken to train a surrogate GEMM is certainly incomparable
with respect to current traditional frameworks, we consider the time it takes to
alter/mutate and compute its objective. Figure 4.17 explores this relationship
with a benchmark graph. We use the open-source MILP solver - GLPK as our
default solver to compute the objective flux of an e_coli_core model. The
benchmark was performed on a Macbook Air 2021 (M1) on a single thread.
GLPK works comparatively better than our DeepGEMM framework with
up to 100 alterations but, however, shows a lack of scalability as the number of
alterations/mutations increase and diverge over time. Meanwhile, our
DeepGEMM framework exhibits flux computations in almost constant time
irrespective of the number of models required to compute. This is due to the fact
that models, once trained, can efficiently compute solutions for multiple
instances irrespective of the number of instances itself. This significantly boosts
the processing time it takes to compute multiple instances of model mutations
simultaneously.
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Figure 4.17 number of alterations/mutations versus time to compute flux.
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Chapter 5
Summary and Future Work
Unwinding the facts within the genotype-phenotype relationship helps us get
closer to understanding what makes biological systems behave the way they do.
Genome-Scale Metabolic Models (GEMMs) offer us a snapshot of the metabolic activity
within the biochemical pathways of a given organism under certain constraints.
Accurately predicting the growth of wild-type reactions subjected to environmental
constraints purely in silico is an improvement process in the field of Systems Biology. In
this thesis, we used a Wasserstein Conditional GAN (with Gradient Penalty) (WCGAN-GP)
to help learn and generate flux distributions of interacting reactions within metabolic
pathways by using annotated Genome-Scale Metabolic Models and purely synthetic data
generated using Monte-Carlo-based simulations and Flux Balance Analysis (FBA). First,
we trained our WCGAN-GP using synthetically generated data from 3 GEMMs
representing different organisms.
In this thesis, we have limited our research to certain assumptions. First,
wild-type growth in the real biological world is directly correlated with respect to time.
FBA, in its purest form, is also limited to the organism being observed in steady-state
alone. In our future work, we consider broadening the applications of DeepGEMM to
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more modeling paradigms - namely kinetic models, PBPK (physiologically-based
pharmacokinetic) models, agent-based and multi-scale models.
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